Vaccine Delivery System Engineers design, develop, and refine the tools and technologies used to administer vaccines efficiently and safely across diverse settings. Their innovations span from conventional syringes and auto-disable injectors to advanced solutions like microneedle patches, jet injectors, and oral or nasal delivery systems. Their designs prioritize accurate dosing, sterile conditions, ease of operation, convenient transport, and adherence to cold chain standards. These systems must work reliably in both high-tech facilities and remote or resource-limited environments, making thoughtful design and rigorous testing critical to their success.
These engineers also collaborate with manufacturers, public health teams, and logistics specialists to ensure vaccine delivery systems are scalable, cost-effective, and ready for real-world deployment. They test materials for durability, design packaging to protect vaccine integrity, and optimize devices for mass immunization efforts. They play a key role in cutting down vaccine wastage, preventing errors during administration, and enhancing vaccine access for marginalized populations. During global health emergencies, such as pandemics, their designs enable rapid and widespread vaccine deployment. As immunization strategies evolve, Vaccine Delivery System Engineers continue to innovate, supporting safer, more efficient vaccine access worldwide. Their contributions are vital in overcoming logistical challenges and ensuring that life-saving vaccines reach every corner of the globe. Through continuous research and development, they help build a healthier future for all communities.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe